Status:
RECRUITING
ALI/ARDS Clinical Sub-phenotyping Study
Lead Sponsor:
China-Japan Friendship Hospital
Conditions:
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Eligibility:
All Genders
18+ years
Brief Summary
1. Construct a structured clinical data and biosample information platform for Chinese patients with acute lung injury/ acute respiratory distress syndrome. 2. By deciphering the heterogeneity of pati...
Detailed Description
Acute lung injury/ acute respiratory distress syndrome is one of the most common and complex critical illnesses in clinical practice, with a high mortality rate of 45% to 50%. Currently, effective the...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria for Acute Respiratory Distress Syndrome (ARDS) according to the updated global definition in 2023.
- The patient or their legal representative signs an informed consent form.
Exclusion
- Individuals aged less than 18 years old.
- Those who refuse to participate in the study.
Key Trial Info
Start Date :
December 14 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06123962
Start Date
December 14 2023
End Date
December 31 2025
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jingen Xia
Beijing, China